T3D Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- T3D Therapeutics's estimated annual revenue is currently $3.4M per year.
- T3D Therapeutics's estimated revenue per employee is $201,000
Employee Data
- T3D Therapeutics has 17 Employees.
- T3D Therapeutics grew their employee count by 0% last year.
T3D Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Founder and CEO | Reveal Email/Phone |
2 | CSO | Reveal Email/Phone |
3 | Director, Clinical Development | Reveal Email/Phone |
4 | Chief Scientific Officer | Reveal Email/Phone |
5 | Executive Director Clinical Development | Reveal Email/Phone |
6 | Director, Clinical Development | Reveal Email/Phone |
7 | Chief Scientific Officer | Reveal Email/Phone |
T3D Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.8M | 29 | 4% | N/A | N/A |
#2 | $3.2M | 16 | 0% | N/A | N/A |
#3 | $83.2M | 414 | 7% | N/A | N/A |
#4 | $31M | 154 | 56% | N/A | N/A |
#5 | $66.6M | 265 | 0% | $35M | N/A |
#6 | $10.9M | 54 | 6% | N/A | N/A |
#7 | $6.8M | 34 | -6% | N/A | N/A |
#8 | $165.7M | 216 | 14% | $250.7M | N/A |
#9 | $26.5M | 132 | -11% | $637.8K | N/A |
#10 | $49.4M | 246 | 6% | N/A | N/A |
What Is T3D Therapeutics?
T3D Therapeutics' mission is to develop its lead drug product candidate, T3D-959, as a potential ‘First-in-Class' and ‘Best-in-Class' disease-modifying, breakthrough medicine for the treatment of Alzheimer's disease with the potential to slow, stop or reverse the course of the disease. The Company is also seeking to maximize the therapeutic utility of T3D-959 and has initiated pre-clinical studies in Huntington's Disease models.
keywords:N/A
N/A
Total Funding
17
Number of Employees
$3.4M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
T3D Therapeutics News
... CymaBay Therapeutics Inc, Genfit SA, Inventiva, Mitobridge Inc, Nippon Chemiphar Co Ltd, Senju Pharmaceutical Co Ltd, T3D Therapeutics...
... Describe the current therapeutic landscape of AD treatments with a focus on ... Merck & Co., Inc, Novo Nordisk, Syneos, T3D Therapeutics
T3D Therapeutics, Inc. is a privately held, Research Triangle Park, NC-based company. The Company has an exclusive license to T3D-959, its lead...
Other Companies in Durham
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $2.6M | 17 | -26% | N/A |
#2 | $1.5M | 17 | -35% | N/A |
#3 | $2.6M | 17 | 6% | N/A |
#4 | $1.5M | 17 | 6% | N/A |
#5 | $1M | 17 | 6% | N/A |